Findings of scientific misconduct.

FINDINGS OF SCIENTIFIC MISCONDUCT 

NIH GUIDE, Volume 26, Number 13, April 25, 1997

 

P.T. 34



Keywords:

  Ethics/Values in Science & Technol 

  Grants Administration/Policy+ 

 

Department of Health and Human Services

 

Notice is hereby given that the Office of Research Integrity (ORI)

has made a final finding of scientific misconduct in the following

case:

 

Fugang Li, Ph.D., University of Oklahoma Health Sciences Center:

Based upon a report from the University of Oklahoma, information

obtained by the Office of Research Integrity (ORI) during its

oversight review, and Dr. Li~s own admission, ORI found that Dr. Li,

a former postdoctoral fellow in the Department of Biochemistry and

Molecular Biology, University of Oklahoma Health Sciences Center,

engaged in scientific misconduct by fabricating and falsifying data

in conducting and reporting research supported by a grant from the

National Heart, Lung and Blood Institute (NHLBI), National Institutes

of Health (NIH).

 

Specifically, Dr. Li fabricated and falsified data in a study

involving the characterization of glycoprotein binding to P-selectin

on the surface of human leukocytes.  The questioned data were

included in a manuscript that was withdrawn prior to publication.

 

Dr. Li has accepted the ORI finding and has entered into a Voluntary

Exclusion Agreement with ORI in which he has voluntarily agreed to

exclude himself, for the three (3) year period beginning June 3,

1997, from:

 

(1) any contracting or subcontracting with any agency of the United

States Government and from eligibility for, or involvement in,

nonprocurement transactions (e.g., grants and cooperative agreements)

of the United States Government as defined in 45 C.F.R. Part 76

(debarment Regulations); and

 

(2) serving in any advisory capacity to the Public Health Service

(PHS), including but not limited to service on any PHS advisory

committee, board, and/or peer review committee, or as a consultant.

 

No scientific publications were required to be corrected as part of

this Agreement.

 

INQUIRIES

 

For further information contact:

 

Acting Director, Division of Research Investigations

Office of Research Integrity

5515 Security Lane, Suite 700

Rockville, MD  20852

Telephone:  (301) 443-5330

 

.